Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocolDaphnée Brazeau, Amelie A Deshaies, David Williamson, Francis Bernard, Caroline Arbour, Anne Marie Pinard, Dominique Rouleau, Louis De Beaumont
20 February 2025
Inhaled methoxyflurane (Penthrox) use in the outpatient and ambulatory setting: a systematic reviewBibi Zeyah Fatemah Sairally, Prathiba M De Silva, Paul Smith, T Justin Clark
17 February 2025
Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in JordanLobna Gharaibeh, Mariam Ahmad Alameri, Mai I AL-Hawamdeh, Enas Daoud, Randa Atwan, Zainab Lafi, Zainab Zaki Zakaraya
8 February 2025
Cross-sectional patient survey of biological medicine users in Finland to investigate the types of guidance needed by patients in order to carry out their treatment successfullyMari Pölkki, Tuire Prami
15 January 2025
Physician’s perception and practices on antimicrobial resistance in a tertiary care hospital in Bangladesh: a cross-sectional studyMohibbul Haque, Mohammad Rezaul Karim, Sabrin Shohid, Shadman Sakib Choudhury, Pilot Hossain, Rotna Rani Sen, Chaity Dey, Sumaiya Khan, Meherun Nahar Munni, Sonia Afroze Shopna, Razia Shultana, Md Fuad Al Fidah, Md Abdullah Saeed Khan, Nasreen Farhana
22 December 2024
Determining the feasibility of linked claims and vaccination data for a COVID-19 vaccine pharmacoepidemiological study in Germany—RiCO feasibility study protocolNina Timmesfeld, Peter Ihle, Robin Denz, Katherina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski, Hans H Diebner, Ingo Meyer
22 December 2024
Efficacy and safety of rivaroxaban in preventing venous thromboembolism in postoperative patients with gynecological malignancies: protocol for a randomised controlled open-label trial (G-alfalfa trial)Ting Wei, Hong Zhou, Shuyi Wu, Fei He, Huan Yi, Jinhua Zhang
20 December 2024
Mapping evidence on the regulations affecting accessibility, availability and management of snake antivenom globally: a scoping review protocolRamsha Majeed, Janette Bester, Kabelo Kgarosi, Morné Strydom
20 December 2024
Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trialStefan Stewart, Enrique Seco-Meseguer, Elena Diago-Sempere, Alicia Marín-Candón, Montserrat Carmona, Miriam Estébanez, Luis A López-Fernández, Iñaki Imaz-Iglesia, María del Mar García Saiz, Emilio J Laserna-Mendieta, Ana M Peiró, Magí Farré, Consuelo Rodriguez-Jimenez, Miriam Saiz-Rodriguez, Judith Sanabria-CabreraSee the full list of authors
7 November 2024
Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocolEnrique Bandín-Vilar, Ana Estany-Gestal, Teresa Cabaleiro, Eva Rial-Pensado, Ana Castro-Balado, Iria Varela-Rey, Cristina Mondelo-García, Francisco Cajade-Pascual, María Teresa Rodríguez-Jato, Irene Zarra-Ferro, María Teresa Rey-Rilo, Jorge Arca-Suárez, María Sandra Albiñana-Pérez, Pedro Rascado-Sedes, Antonio Pose-ReinoSee the full list of authors
29 October 2024